Application of wheat aphid growth and development related gene PLRP1 as target in aphid control

By using dsRNA interference technology of PLRP1, a gene related to the growth and development of wheat aphid, combined with a nanomaterial delivery system, the problems of environmental pollution and pesticide resistance in wheat aphid control were solved, achieving safe and efficient pest control.

CN118956870APending Publication Date: 2024-11-15INST OF PLANT PROTECTION CHINESE ACAD OF AGRI SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411094193.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-09
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing technologies are insufficient to effectively control wheat aphids, the use of chemical pesticides leads to environmental pollution and pesticide resistance problems, and there is a lack of effective aphid-resistant wheat varieties.

Method used

By utilizing the dsRNA of PLRP1, a gene related to the growth and development of the wheat aphid, and silencing the PLRP1 gene in the wheat aphid through RNA interference technology, combined with a nanomaterial delivery system, pest control can be achieved.

Benefits of technology

It achieves a specific insecticidal effect against wheat aphids, leaves no environmental residues or toxicity, is highly safe, and reduces the use of chemical pesticides.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004987388320000031
    Figure BDA0004987388320000031
  • Figure BDA0004987388320000051
    Figure BDA0004987388320000051
  • Figure BDA0004987388320000061
    Figure BDA0004987388320000061
Patent Text Reader

Abstract

The invention belongs to the field of biotechnology and plant protection, and discloses application of a wheat aphid growth and development related gene PLRP1 as a target in aphid control. The dsRNA of the macrosiphum avenae growth and development related gene PLRP1 is obtained, and the PLRP1 gene in the macrosiphum avenae body is silenced by an RNAi technology by adopting a method of delivering the dsRNA through a nano material, so that the macrosiphum avenae generates a lethal effect. Results show that the conserved sequence of the sitobion avenae growth and development related gene PLRP1 can be used as a potential molecular target for research and development of RNA biopesticide for prevention and control of sitobion avenae. The method for preventing and controlling pests through RNA interference has the following advantages: 1) the pest killing specificity is realized, and the killing effect on non-target organisms is avoided; 2) RNA is easy to degrade in nature and has no residue; and 3) being non-toxic and harmless to the environment and relatively safe.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biotechnology and plant protection, and specifically relates to the use of a wheat aphid growth and development-related gene PLRP1 as a target in preventing and controlling aphids. Background Art

[0002] Wheat aphids are a worldwide pest, primarily found in temperate and subtropical regions of the Northern Hemisphere and in all wheat-producing countries worldwide. Wheat aphids can cause damage throughout the wheat's entire growth period. During the seedling stage, wheat aphids primarily gather on leaves and sheaths, feeding on the sap of the wheat plant's stems and leaves. After heading, wheat aphids concentrate their damage on the stems, leaves, and ears, excreting honeydew that affects the plant's respiration and photosynthesis. The grain filling and milky stages of wheat are peak periods for wheat aphid damage, causing shriveled grains and reduced thousand-grain weight, resulting in severe yield losses.

[0003] Currently, wheat aphid control relies primarily on spraying chemical pesticides. However, the extensive use of chemical pesticides is not only harmful to humans and animals and causes serious environmental pollution, but also represents a significant challenge to aphid control efforts as aphids have developed resistance to some commonly used chemical insecticides. We propose that wheat aphid control should adhere to a "prevention-first, integrated control" approach to plant protection. This approach should incorporate multiple control methods, utilize synergists to reduce the use of chemical pesticides, strengthen monitoring of aphid resistance, and promptly reduce or prohibit the use of insecticides to which aphids have developed high resistance, thereby mitigating or delaying the development of resistance. Furthermore, developing aphid-resistant wheat varieties is the most effective approach to controlling aphid infestations. However, due to the lack of effective aphid-resistant genes in existing germplasm resources and the unclear mechanisms of resistance, conventional breeding is difficult to achieve. There is an urgent need to identify and utilize new aphid-resistant genes and improve wheat aphid resistance through genetic engineering. This is crucial for developing new, environmentally friendly, and sustainable aphid control methods.

[0004] RNAi is a highly conserved tool for regulating gene expression in animals, plants, and microorganisms. Currently, the most commonly used RNAi-inducing factor is dsRNA. Upon entering the insect body, dsRNA is randomly cleaved by the Dicer protein into small RNAs (about 22 nucleotides in length). These small RNAs bind to Argonaute proteins (AGOs) to form RNA-induced silencing complexes (RISCs). These complexes complement the target RNA strand, inducing mRNA degradation or inhibiting translation. RNAi technology can effectively target essential genes in pests, achieving efficient gene silencing and effectively controlling pests and diseases. Pest control using RNA interference has the following advantages: 1) insecticide specificity, with no killing effect on non-target organisms; 2) RNA is easily degraded in nature, leaving no residue; and 3) it is environmentally nontoxic and relatively safe. RNA biopesticides have been called the "third revolution" in pesticide history, and therefore, RNAi technology has become a major research direction for future pest control.

[0005] Pancreatic lipase-related protein 1 (PLRP1, also known as APLP1) is a member of the pancreatic lipase family and shares high sequence similarity with pancreatic lipase (PTL), but differs in function. Ren et al. investigated the biological functions of PLRP1 knockout (KO) mice and found that PLRP1 KO mice maintained similar body weight to wild-type mice before adulthood. However, in adulthood, PLRP1 KO mice exhibited obesity, accompanied by increased fat mass, impaired glucose clearance, and consequent insulin resistance (Jianke Ren, et al. Increased fat mass and insulin resistance in mice lacking pancreatic lipase-related protein 1. Journal of Nutritional Biochemistry 22 (2011) 691–698). These findings suggest that PLRP1 may influence energy balance and metabolic homeostasis by regulating the classic pancreatic lipase-colipase-mediated digestion of dietary triglycerides. In addition, PLRP1 may be associated with obesity and acute pancreatitis (AP), and changes in its expression or activity may affect the occurrence and development of these diseases (Yu Bingjun, Li Nianshuang, He Cong, Wan Jianhua, Lv Nonghua, 2021. Research progress of pancreatic lipase family in acute pancreatitis and obesity. Chinese Journal of Pancreatology, 21(2): 156-159.). Providing innovation for the treatment of obesity. The binding ability of PLRP1 with potential inhibitors such as flavonoids was explored by molecular docking technology, providing new molecular targets and therapeutic strategies for the treatment of obesity (Rajan, L., Das, N., Chakkyarath, V., Natarajan, J., Palaniswamy, D., Siddhartha, SS, Mishra, K. (2023). Pancreatic lipase related protein 1 as a potential target in triglyceride breakdown: Amolecular docking studies with in vitro appraisal. Results in Chemistry, 5, 100960.). In summary, PLRP1 has a potential role in human metabolic diseases and may become a target for future therapeutic strategies. However, further studies are needed to fully understand its specific mechanisms of action in physiological and pathological processes.

[0006] However, the application of the growth and development-related gene PLRP1 and its dsRNA in pest control has not been reported. Summary of the Invention

[0007] The invention obtains dsRNA of the growth and development-related gene PLRP1 of the aphid, adopts a method of delivering the dsRNA with nanomaterials, and utilizes RNAi technology to silence the PLRP1 gene in the aphid, resulting in a lethal effect on the aphid.

[0008] The present invention provides an application of a wheat aphid growth and development related gene PLRP1 as a target in preventing and controlling aphids, wherein the nucleotide sequence of the wheat aphid growth and development related gene PLRP1 is shown in SEQ ID NO: 1.

[0009] Specifically, the method designs dsRNA using the wheat aphid growth and development-related gene PLRP1 as a target, and applies the dsRNA to aphids to achieve the purpose of prevention and control.

[0010] More specifically, the nucleotide sequence of the dsRNA is shown in SEQ ID NO: 4.

[0011] Preferably, the aphid is wheat aphid, more specifically Macrosiphum avenae.

[0012] The present invention provides application of dsRNA targeting wheat aphid growth and development-related gene PLRP1 in preventing and controlling aphids.

[0013] Specifically, the aphid is wheat aphid, more specifically Macrosiphum avenae.

[0014] Preferably, the nucleotide sequence of the dsRNA is shown in SEQ ID NO: 4.

[0015] The present invention also provides a method for controlling aphids, comprising the step of applying dsRNA targeting the wheat aphid growth and development-related gene PLRP1 to the aphids, for example, by spraying a medicament containing the dsRNA.

[0016] Specifically, the aphid is wheat aphid, more specifically Macrosiphum avenae.

[0017] Preferably, the nucleotide sequence of the dsRNA is shown in SEQ ID NO: 4.

[0018] The results of this study indicate that the conserved sequence of the PLRP1 gene, which is associated with the growth and development of the wheat aphid, could serve as a potential molecular target for the development of RNA-based biopesticides for the control of the aphid. Pest control through RNA interference has the following advantages: 1) insecticide specificity, with no killing effect on non-target organisms; 2) RNA is easily degraded in nature, leaving no residue; and 3) it is environmentally non-toxic and relatively safe. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 Amplification curves, standard curves, and melting curves of some mRNAs.

[0020] Figure 2 Relative expression analysis of candidate target genes at different developmental stages of the two-winged aphid (Aphididae). Pe: pseudoembryo; N1-4: 1st-4th instar nymphs; Ad: adult aphid. Data are mean ± standard error. Different lowercase and uppercase letters indicate significant differences in gene expression between winged and wingless aphids at different developmental stages (P < 0.05, LSD test). P values ​​indicate significant differences in gene expression between two-winged aphids at the same developmental stage (significant P < 0.05, extremely significant P < 0.01); NS indicates non-significant differences (t-test).

[0021] Figure 3 , PCR product gel electrophoresis. M stands for maker, and lanes 1-6 represent the PCR product bands of AP-1, APT1, BNIP3, RBPs, Vmp1, and PLRP1, respectively.

[0022] Figure 4 , dsRNA gel electrophoresis. M stands for maker, and lanes 1-6 represent the dsRNA product bands of AP-1, APT1, BNIP3, RBPs, Vmp1, and PLRP1, respectively.

[0023] Figure 5 , GFP PCR products and dsGFP gel electrophoresis. M stands for maker, lane 1 is the GFP PCR product, and lane 2 is the GFP dsRNA product.

[0024] Figure 6 , RNAi interferes with the mortality rate of first-instar nymphs of wheat aphid before adulthood. DETAILED DESCRIPTION

[0025] The following further describes the content of the present invention in detail by combining the accompanying drawings and specific embodiments. The specific embodiments are provided to facilitate a better understanding of the present invention, but are not intended to limit the present invention in any way.

[0026] Example 1: miRNA target gene prediction and analysis

[0027] TargetScan and miRanda online target gene prediction software were used to predict miRNA target genes from differentially expressed genes. KEGG pathway enrichment analysis and relevant literature reports were combined to screen genes as candidate miRNA target genes. Combined with KEGG pathway enrichment analysis, 10 genes were ultimately identified as candidate target genes for miR-263 (Table 1). They are AP-1 (activating protein-1), APT1 (acyl protein thioesterase 1), PLRP1 (pancreatic lipase-related protein 1), Vmp1 (vacuole membrane protein 1), BNIP3 (BCL2 / adenovirus E1B interacting protein 3), Mrp4 (multidrug resistance protein 4), ALP (alkaline phosphatase), UGTs (UDP-glycosyltransferases), RBPs (RNA binding proteins), and SCARB1 (scavenger receptor B class I). Their specific functions and pathways are shown in Table 1.

[0028] Table 1. Analysis of candidate target genes of miR-263

[0029]

[0030] Among them, the nucleotide sequence of the PLRP1 gene (SEQ ID NO: 1):

[0031] CTCGGACAAGACGGTAGGAAAATAAAAATTCAAGACGCCGCCGCCCGCCGCCTCCGTTCACTTTCACT

[0032] CGGACGGCTCGCTCGCGACTTCTGCCAACGACAACAGTCGACAGTCATTCAGTTACCCGCTGGTCGC

[0033] GAGCGCCTCAGCTGCTGCGGTGGTCACGGATAGAGACAGAGTACGTCGCGCCTTACAGACACGGA

[0034] AAATCCGGAAAATTCGCACAATGATCTGACACCAAGCATGAACATGAAAGAGCCATGGCCGGCCATA

[0035] CAATCACGAGTTACCAAACATTGCTATACCTGTTCACGTTCGTCGCAATCGGCGAAATACTGTGTCAG

[0036] GGTAGAGACACCCCTGCAGCGAGATTTCAGACGCCACTGCCGAAGGGGCGCGCCATACCTGTAGCCT

[0037] CCGCCAACGGAGGTCCTGCAGCGAACGTCATCGGCCGCCCGACCAAGCAACAGCAGCAGGACGCCG

[0038] TCCAGAAACAGACCACGCCGACTCCGCCGGTCTCGGTCAAAGAGCTGTTCAACTCTTCGTCGTGCGT

[0039] CGAACCTCCGTTCACGTGCCCTCATCCGAAGATCCAGTTTTACTTGTACACCAGGCTCACGCAGAACA

[0040] ATCCCGACTTGATGGACGTGACCGACCCGGAATCGCTGTACACGTCACATTTCAACCCTAAACATCCG

[0041] GTCAAGATTATCATACACGGATTCCAAGGCGGCCGAAATCTGTCGCCGAGTACCGATCTCCGGAACGC

[0042] TTATTTCACTCGGGGAAACTACAATATAATCATAGTGGACTACTCGAGTTTGGCGCAGATACCTTGTCT

[0043] GAACCAAGTGGAATGGGCTCCTAGATTCTGTGCCATGTGCATCGCTCAACTGGCCAACTACCTGGCCG

[0044] ACCATCCTCGAGGAGTTCCGCCCGACAAGCTGCACATGATGGGATACAGCGTGGGCGCTCACATCGC

[0045] AGGCCTGACGTCCAATTTCATCAACTCGGGAAAAATCGGACGGATCACCGGCTTGGACCCGACGATC

[0046] ATATTCTACATGAGCAACAACCGATCCAGGGACCTCGATCCCACGGACGCTCATTTCGTGGACATCATA

[0047] CACACGGCGGCGGGCATCCTGGGTCAGTGGGGCCCCAGCGGACACGCCGACTTCTACGTGAACGGC

[0048] GGCACTTCGCAGCCCGGCTGCGCCAGTGACAGTATCATTCAGACGCTGTCATGCGATCACACCAAAG

[0049] TGACACCGTACTTCATTGAATCGATCAACTCCAACGTCGGATTTTGGTCATTACCTTGTGCCAACCGAT

[0050] TTTACTTCAACTTGGGCCTTTGCGATCCGCCGGAGTCGGAGTACGTTTTGATGGGCGAACACGTGACA

[0051] CACAAAGCTCGTGGTATTTATTACCTGCACACGAACGCGAAAAAACCTTACGCCAGAGGCTTCCCCA

[0052] AGAAGGCGCTGAAGACGTGATTGTCATTGTCAACCTGCAACCGTGCGCGGACCTTTGCAACCTCCCG

[0053] CAACGATATACTCTTTATGATAATAAAATATACGAAAAAAAGACCTAGTCAAATAATATTATGTGTATTAT

[0054] TAATATTGTTTTGTGCGCACTGGCACATGTACAGAATAGAATATATTATTTTAATCTATTCTGTGCCGACA

[0055] TCGTCCGCATATTATAATATTATAAGACCTTAGATCATATACAACGGACAGAGCCACTATGTATTATAAAT

[0056] GCGCACTGTTTAAAGACATCATTATCGACGAGCCGCCAGAGGACTGACTTCAGCTATCGCTAATACGT

[0057] GTCAGTATACTCGTCGCATATTTATCATACTATTATACGGGTACAGTGAAACTTCCATAATATCACGAAG

[0058] TCTCGCGAGCAACGAAAAAAATTCGTATCATAGAGAATTTCTTTAGATAGAATTTAGAAATAAATTTTC

[0059] AAATTTCAAATTTGGTTTGCTTCATACAAATATGTCTTTAAACAGAAAATGTTGTCGAATGGAAGTTTC

[0060] ACTGTTTGTCAAGTCATAACCAGCGATGACACAAATTGCACGTGATAACGGATGTACTTACCAACCGA

[0061] ATGTGAATTTTCCTCAATTCCATTACCATTGTTGTTGTGTTGGCTTCAAACATTTAGTCAGGTGTAGCTC

[0062] TATCCATTGTGTATAATATGATCTAAGTATAAAGACATACATACTTTTATTGATAATTATAAAATGGTTATA

[0063] TTATCTCGTGTTGTATATACTTCCCTCGTGCTTATTACCGCGTACATACATATATATTGATTCTGTATATATT

[0064] TATCCGGACGGTGAATGTTTCAAGTTTTTTGTGATCATAGATTATAATATTTTGTAAAATAATTATTTTCTG

[0065] TGTATAAAATAGACAAATAGTGTTACTGCAGCGTAAAATAGTCAATACTGGTGTATTATAGTTGTAAACT

[0066] TGTAGTATAATTCATTCATACAACAGTGTCGTATATTATTGTTCGATCGTTTTGAAACATTAAGTTGGA

[0067] ACGAAAACGCAAATAATTGTATTATAATATATATTATGTGTATTAGGATTAGGCACGTGCGTCGTGCAGA

[0068] CGATAAATGTCGAGAAAAAAAATGTCAATTTAGTTTAGAATAATTAGTAAAAATTGGTCTAGTGGTAAT

[0069] GAATAAATATGAACATTATTATTTTATTATGACGCGTCCCAATAATAATATAATATAGGTATTAGTAGTATA

[0070] TGAAATTTCCTATTATGACATCACAATCGAAAATTGTATTTTATTGCCATATATATTATTATTATATTACAATTATTGAAAATAAAATGTTTATTGTAACCGA.

[0071] Example 2: Verification of the lethal function of miR-263 candidate target genes

[0072] 1. Collection of two-winged wheat aphids at different ages

[0073] Collection of winged aphids at different instars: 3rd to 4th instar nymphs reared from single colonies were transferred to Petri dishes containing fresh wheat seedlings (30 per dish). To ensure adequate nutrition during aphid rearing, fresh hydroponic wheat seedlings were replaced every 5 days. Aphids were treated with 5 μL of 1000 ng / μL EβF using a pipette, dripped into the Petri dishes. This treatment was repeated 5 times daily for 5 consecutive days, with 2 hours between treatments. Any adult aphids that produced nymphs were promptly removed. Six treatment groups were established, with 6 replicates per group. After the 5-day EβF treatment, aphids were collected as indicated: 1) From the first group, pseudoembryos were collected by squeezing the abdomens of adult aphids with an insect pin; 2) Newly born nymphs produced within 24 hours from the second group were collected as first-instar winged nymphs; 3) Newly born nymphs produced within 24 hours from the second, third, and fourth groups were reared individually in Petri dishes, and samples of 2nd, 3rd, and 4th-instar winged nymphs were collected according to the number of molts. 4) Newly born nymphs produced within 24 hours by aphids from group 6 were reared at a density of 30 per dish in a petri dish containing fresh wheat seedlings. After growing into winged adult aphids, pseudo-embryos were removed and winged adult aphid samples were collected.

[0074] Collection of wingless aphids at different instars: 3rd to 4th instar nymphs reared from single colonies were transferred to Petri dishes containing fresh wheat seedlings (6 per dish). To ensure adequate nutrition during aphid rearing, fresh hydroponic wheat seedlings were replaced every 3 days to ensure wingless aphid production. Six treatment groups were set up, each with 6 replicates. After aphids matured, they were collected as follows: 1) Newly born nymphs produced within 24 hours from aphids in group 1 were collected as wingless 1st instar nymph samples. 2) Newly born nymphs produced within 24 hours from aphids in groups 2, 3, and 4 were reared individually in Petri dishes, and 2nd, 3rd, and 4th instar wingless nymph samples were collected based on the number of molts. 3) Aphids in group 5 were collected and their abdomens squeezed with an insect needle to collect wingless pseudo-embryos as samples. 4) Newly born nymphs produced within 24 hours from aphids in group 6 (6 per dish) were reared in Petri dishes until they matured into wingless adults. After removing the pseudo-embryos, wingless adult samples were collected. All collected samples were quickly frozen in liquid nitrogen and stored in a −80 °C freezer until use.

[0075] 2. Primer design

[0076] Further research was conducted on six of the ten genes with potential lethal effects. mRNA quantitative PCR primers and PCR amplification primers were designed using PrimerPremier 5 (Tables 2 and 3). Primer synthesis was performed by Qingke Bioengineering (Beijing). These primers were diluted to a 10 μM working solution for later use.

[0077] Table 2. Fluorescence quantitative PCR primers

[0078]

[0079]

[0080] Table 3. Primers for dsRNA amplification of 6 mRNAs and GFP

[0081]

[0082] Note: TAATACGACTCACTATAGGG It is a T7 sequence.

[0083] 3. cDNA Synthesis

[0084] Dilute the extracted total RNA to the same concentration and perform the reverse transcription according to the instructions of the reverse transcription kit. The specific reaction system is as follows:

[0085] Reagents Volume (μL) Total RNA 1 Mix 4 <![CDATA[ddH2O]]> 15 Total volume 20

[0086] The reaction conditions were 42°C for 15 minutes and 95°C for 3 minutes. After the PCR instrument cooled to room temperature, the cDNA was removed, diluted 5-10 times, and stored in a -20°C freezer.

[0087] 4. Standard curve

[0088] cDNA was divided into 5 -1 , 5 -2 , 5 -3 , 5 -4 , 5 -5 The diluted cDNA was used as a template to prepare a standard curve.

[0089] 5. Fluorescence quantification

[0090] The qRT-PC reaction system and reaction conditions were carried out according to the instructions of the SuperReal Fluorescence Quantitation Premix Reagent Enhanced Kit (https: / / www.tiangen.com / content / details_71_23923.html).

[0091] 6. dsRNA Preparation

[0092] Among them, the dsRNA targeting the wheat aphid growth and development-related gene APT1 is (SEQ ID NO: 2):

[0093] TAATACGACTCACTATAGGGCTGGAGTTATGGCTCTATCTTGTTGGATACCATTACATAAAACTTTTCCA

[0094] GCAGCTGCTGTAAGTAACAAAGATATGCCAATAATTCAGTGTCACGGAGATTGTGATCCAATTGTACC

[0095] ACTAAAATGGGGTCAACTTACAGCATCCATTCTTAAGTCTTTTGCTAAACATACCGAACTGAAAACCTACCG.

[0096] The dsRNA targeting wheat aphid growth and development-related genes RBPs is (SEQ ID NO: 3):

[0097] TAATACGACTCACTATAGGGGATGGAACAAGATGTTGTGGATCCAGAATTATTGTTCAAATGTCAA CTGGAAAACGTTCCAGAGATAAATCACCTGTACATAGAGGACGATCTTCACCTTCACGGCGGGGTTAT CGTTCATATTCAAAATCACAATCAAGGAGTCGCTCACCAGTTTACAGAA.

[0098] The dsRNA targeting the wheat aphid growth and development-related gene PLRP1 is (SEQ ID NO: 4):

[0099] TAATACGACTCACTATAGGGCGGAGTCGGAGTACGTTTTGATGGGCGAACACGTGACACACAAA GCTCGTGGTATTTATTACCTGCACACGAACGCGAAAAAACCTTACGCCAGAGGCTT.

[0100] The dsRNA for gene AP-1 is (SEQ ID NO: 5):

[0101] TAATACGACTCACTATAGGGCGAAGCGCTCAAATGCCTACACCACAACAACGATTCTAACAGTGCCACTCAAGTAGAAATACCAATGACTAGCAGTGGTAGTAATTCTTCGGAATACCAATCGGAACCCCAGTACTCTGTGTTAATGACTTCAAATGACTTTTCCAATATTATACCTCAACATGTTATCAAAGAAGAACCTCAAACTGTACCCAGTGTCACGTCTTCGTCA.

[0102] The dsRNA for the gene BNIP3 is (SEQ ID NO: 6):

[0103] TAATACGACTCACTATAGGGATTGGAGTAGCCGACCAGACCAGGCACCTCCCAAAAACTGGAAATTCATTCATCCCAGAAGAAGACATACAGTATGCGCAATGCCAAGGTCGGCAAAGACGGCCTCTTTTCCAAAGAAGTTTTGTACACTTTGTTCCTGACCAATATTTTATCCATACTGCTGGGAGCTGGCGTTGGTGCCTGGCTATGTAAACGAGGCGGTA.

[0104] The dsRNA for the gene VMP is (SEQ ID NO: 7):

[0105] TAATACGACTCACTATAGGGAACCGTCCACCGACTGATTCTAAGCCCAGATCAAGACCGAAGAA AATCGACAAAGTATTACAAAACGGCCAGAGTAATTCTAAATTCAAACAACTTAAAAAATCAGCAAAAATGGATGTCCACTCACTTGTGGTATG.

[0106] 1) GFP plasmid extraction

[0107] a) Add 10 μL of GFP bacterial solution to a centrifuge tube containing 1.5 mL of LB liquid medium and culture overnight on a constant temperature shaker at 37°C and 200 rpm.

[0108] b) Column equilibration: 500 μL of equilibration solution BL was added to the adsorption column CP4, centrifuged at 13,000 rpm for 1 min, and the waste liquid was discarded.

[0109] c) Take the overnight cultured GFP bacterial solution and centrifuge it in a high-speed refrigerated centrifuge at 13,000 rpm for 1 minute. Discard the supernatant and collect the bacteria at the bottom of the centrifuge tube.

[0110] d) Resuspend the bacterial pellet at the bottom of the tube with 300 μL of Buffer P1 and vortex for about 10 seconds.

[0111] e) After bacterial suspension, add 300 μL of Buffer P2, mix thoroughly to completely lyse the bacteria, and let it stand at room temperature for 5 to 10 minutes.

[0112] f) Add 300 μL of Buffer P4, mix thoroughly, and let stand at room temperature for 5–10 minutes. Centrifuge at 13,000 rpm for 10 minutes. A precipitate will form at the bottom of the tube.

[0113] g) Take the supernatant and add it to the filtration column CS. Centrifuge in a high-speed refrigerated centrifuge at 4°C and 13,000 rpm for 2 minutes. Collect the filtrate in a new centrifuge tube.

[0114] h) Add 0.3 volumes of isopropanol to the filtrate, mix thoroughly, and transfer to adsorption column CP4. Centrifuge in a high-speed refrigerated centrifuge at 4°C, 13,000 rpm for 1 minute, and discard the waste liquid.

[0115] i) 500 μL of PD was added to the adsorption column CP4 and centrifuged at 4°C, 13,000 rpm in a high-speed refrigerated centrifuge for 1 min. The waste liquid was discarded.

[0116] j) 500 μL of PW was added to the adsorption column CP4, and the mixture was centrifuged at 4° C. and 13,000 rpm in a high-speed refrigerated centrifuge for 1 min, and the waste liquid was discarded (repeat twice).

[0117] k) After vacuo for 2 minutes to remove residual liquid, add 100-200 μl of elution buffer TB, let it stand at room temperature for 2-5 minutes, and centrifuge at 13,000 rpm for 2 minutes to collect the plasmid solution.

[0118] 2) PCR product preparation

[0119] PCR reaction system was constructed according to the instructions of PCR amplification kit (Tiangen):

[0120] Components Volume (μL) Amplification template 1 Forward primer 1 Reverse primer 1 2×Taq Plus MasterMix(Dye) 12.5 <![CDATA[RNase-Free ddH2O]]> 9.5 Total volume 25

[0121] PCR reaction process: pre-denaturation at 94°C for about 3 minutes, then 40 cycles of "denaturation-annealing-extension" as follows: denaturation at 94°C for about 30 seconds, primer annealing at 65°C for about 30 seconds (can be set according to the primer Tm value), primer extension at 72°C for about 1 minute, and extension again for about 5 minutes at the end of the last cycle.

[0122] 7. dsRNA purification

[0123] a) Transfer the incubated system into a 1.5 mL enzyme-free centrifuge tube and add 80 μL ddH2O to make up to 100 μL;

[0124] b) Add 10 μL of ammonium acetate and vortex to mix;

[0125] c) Add 3 volumes of anhydrous ethanol and vortex to mix;

[0126] d) Refrigerate the mixed solution at -20°C for at least 30 minutes;

[0127] e) Centrifugation at 13,000 rpm for 15 min at 4°C to precipitate the dsRNA;

[0128] f) Discard the supernatant and add 1000 μL of 75% ethanol solution. Repeat twice.

[0129] g) Remove the remaining liquid and add 15-30 μL ddH2O to dissolve the precipitate, depending on the amount of precipitate;

[0130] h) Taking 1 μL of the mixed dsRNA solution and diluting it to 10 μL for concentration and purity testing;

[0131] i) The purified dsRNA was stored in a -20°C refrigerator for future use.

[0132] 8. RNA interference

[0133] Mix the star-shaped cationic polymer SPc and dsRNA at a 1:1 mass ratio to a concentration of 500 ng / μL. Add 0.5% of the total volume of the surfactant alkyl glycoside and incubate at room temperature for approximately 15 minutes to form the SPc / dsRNA complex. dsGFP served as a control.

[0134] A nanomaterial delivery system-mediated drip method was used to interfere with the growth of one-day-old wheat aphids. The SPc / dsRNA complex (CHEN J, ZHANG D, YAO Q, ZHANG J, DONG X, TIAN H, CHEN J, ZHANG W, 2010. Feeding-based RNA interference of a trehalosephosphate synthase gene in the brown planthopper, Nilaparvata lugens. Insect Molecular Biology, 19(6): 777-786. DOI: 10.1111 / j.1365-2583.2010.01038.x.) was dripped onto the back of the aphids using a microsyringe. After the droplet was completely absorbed by the aphids, the aphids were transferred to a culture dish containing hydroponic wheat seedlings, with 10 aphids per dish for a total of 100 aphids treated. Rearing environment: temperature 21±1℃, relative humidity 60±10%, photoperiod L:D 16:8.

[0135] Results and Analysis

[0136] 1. Primer specificity detection of 10 mRNAs and internal reference HEL

[0137] Correlation coefficient R of the standard curve of 10 mRNAs and internal reference HEL 2 The amplification efficiency was between 90% and 110%, the melting curves were all single peaks, and no primer dimers appeared. -△△Ct The relative expression level of the target gene was calculated by this method. Figure 1 These are the amplification curve, standard curve, and melting curve of some mRNAs.

[0138] Table 4. mRNA primer specificity detection

[0139] Gene Amplification efficiency E(%) <![CDATA[Coefficient of correlation R 2 > AP-1 E=95.8% <![CDATA[R 2 =0.997]]> BNIP3 E=99.9% <![CDATA[R 2 =0.998]]> PLRP1 E=104.6% <![CDATA[R 2 =0.995]]> Vmp1 E=97.7% <![CDATA[R 2 =0.998]]> ALP E=94.1% <![CDATA[R 2 =0.994]]> Mrp4 E=93.0% <![CDATA[R 2 =0.992]]> APT1 E=102.4% <![CDATA[R 2 =0.993]]> SCARB1 E=95.1% <![CDATA[R 2 =0.989]]> RPBs E=93.9% <![CDATA[R 2 =0.991]]> UGTs E=90.3% <![CDATA[R 2 =0.987]]>

[0140] 2. Detection of changes in mRNA expression levels at different ages of two-winged morphs

[0141] Using winged pseudo-embryos as controls, qRT-PCR results showed that 10 mRNAs were expressed in all instars of the two-winged aphid, and their relative expression levels showed a trend of first increasing and then decreasing ( Figure 2 However, the relative expression levels of different mRNAs were different at different developmental stages. The relative expression levels of most mRNAs were low in the pseudo-embryonic stage. Among them, the relative expression levels of four mRNAs (BNIP3, ALP, Mrp4, and Vmp1) showed no significant difference in the pseudo-embryonic stage (t BNIP3 =1.218, P BNIP3 =0.269; t ALP =1.878, P ALP =0.15; t Mrp4 =-0.948, P Mrp4 =0.38; t Vmp1 =-1.515, P Vmp1 =0.181). The relative expression level of AP-1 was highest in 2nd-instar winged nymphs, and was significantly different from that in 2nd-instar wingless nymphs (t AP-1 =6.81, P AP-1 <0.001); the relative expression levels of BNIP3 and Mrp4 were highest in the third-instar winged nymphs, and were significantly different from those in the third-instar wingless nymphs (t BNIP3 =2.836, P BNIP3 =0.029; t Mrp4 =2.878, P Mrp4 =0.028); the relative expression level of PLRP1 was highest in winged adults and significantly different from that in wingless adults (t PLRP1 =2.83, P PLRP1 =0.03); the relative expression levels of ALP and Vmp1 were the highest in wingless adults, and were significantly different from those in winged adults (t ALP =-11.391, PALP <0.001; t Vmp1 =-12.24, P Vmp1 <0.001); the relative expression level of APT1 was highest in the third-instar wingless nymphs and was significantly different from that in the third-instar winged nymphs (t APT1 =-3.166, P APT1 =0.019); the relative expression level of SCARB1 was highest in 2nd-instar wingless nymphs, and was significantly different from that in 2nd-instar winged nymphs (t SCARB1 =-14.219, P SCARB1 <0.001); the relative expression levels of UGTs were highest in winged adult aphids and were significantly different from those in wingless adult aphids (t UGTs =5.333, P UGTs =0.002). The relative expression levels of RBPs were highest in the third-instar winged nymphs and had no significant difference from those in the third-instar wingless nymphs (t RBPs =0.873, P RBPs =0.416).

[0142] In winged aphids, the relative expression level of AP-1 reached its maximum in the second-instar nymph and was significantly different from that in other instars (P<0.05); the relative expression level of BNIP3 reached its maximum in the third-instar nymph and had no significant difference from that in adults, but was significantly different from that in other instars (P<0.05); the relative expression levels of PLRP1, APT1, SCARB1, and UGTs reached their maximum in adults and were significantly different from that in other instars (P<0.05); the relative expression level of ALP reached its maximum in the first-instar nymph and was significantly different from that in other instars (P<0.05); the relative expression levels of Mrp4 and RBPs reached their maximum in the third-instar nymph and were significantly different from that in other instars (P<0.05); the relative expression level of Vmp1 reached its maximum in the third-instar nymph and had no significant difference from that in the second-instar nymph, but was significantly different from that in other instars (P<0.05).

[0143] In wingless aphids, the relative expression level of AP-1 reached its maximum in the second-instar nymph and was significantly different from that in other instars (P<0.05); the relative expression levels of AP-1, BNIP3, Mrp4, APT1, and RBPs reached their maximum in the third-instar nymph and were significantly different from those in other instars (P<0.05); the relative expression level of PLRP1 reached its maximum in the third-instar nymph and was not significantly different from that in the second-instar nymph, but was significantly different from those in other instars (P<0.05); the relative expression level of ALP reached its maximum in adults and was significantly different from those in other instars (P<0.05); the relative expression level of Vmp1 reached its maximum in adults and was not significantly different from that in the third-instar nymph, but was significantly different from those in other instars (P<0.05); the relative expression level of SCARB1 reached its maximum in the second-instar nymph and was significantly different from those in other instars (P<0.05); and the relative expression level of UGTs reached its maximum in adults and was significantly different from those in other instars (P<0.05).

[0144] 3. Functional verification results of candidate target genes

[0145] Double-stranded primers were designed based on the candidate target gene and GFP sequences for PCR product purification and dsRNA purification. Figure 3 、 4 As shown in Figures 5 and 5, the dsRNA and dsGFP gel electrophoresis bands of the candidate target genes were accurately positioned, bright, and single, meeting the requirements of subsequent experiments.

[0146] To determine whether miR-263 candidate target genes have a lethal effect on wheat aphids, six candidate target genes were selected for RNAi functional verification based on relevant literature, namely AP-1, BNIP3, APT1, PLRP1, RBPs, and ALP. First-instar wheat aphid nymphs were subjected to single and three interference treatments (24h intervals), and the mortality rate of wheat aphids before adulthood was calculated. The results are as follows: Figure 6 As shown. A single knockout of PLRP1, APT1, and RBPs resulted in mortality rates of 48.33%, 48.66%, and 23%, respectively, significantly different from the GFP mortality rate of the control group (11%). A single knockout of AP-1, BNIP3, and Vmp1 resulted in mortality rates of 10%, 9%, and 13%, respectively, which were not significantly different from the GFP mortality rate of the control group (11%). A three-time knockout of PLRP1, APT1, and RBPs resulted in mortality rates of 56%, 67%, and 72.33%, respectively, which were significantly different from the GFP mortality rate of the control group (33%). A single knockout of AP-1, BNIP3, and Vmp1 resulted in mortality rates of 31.33%, 29.67%, and 35%, respectively, which were not significantly different from the GFP mortality rate of the control group (33%). These results indicate that PLRP1, APT1, and RBPs are lethal to Aphid avenae, while AP-1, BNIP3, and Vmp1 have no significant lethal effect on Aphid avenae.

Claims

1. A gene related to wheat aphid growth and development PLRP1 Application of wheat aphid growth and development related genes as targets in aphid control PLRP1 The nucleotide sequence is shown in SEQ ID NO:

1.

2. The use according to claim 1, characterized in that wheat aphid growth and development related genes PLRP1 The dsRNA is designed as a target and applied to aphids to achieve the purpose of control.

3. The use according to claim 2, characterized in that The nucleotide sequence of the dsRNA is shown in SEQ ID NO:

4.

4. The use according to claim 1, characterized in that The aphid is wheat aphid, more specifically Macrosiphum avenae.

5. Targeting genes related to wheat aphid growth and development PLRP1 Application of dsRNA in controlling aphids.

6. The use according to claim 5, characterized in that The aphid is wheat aphid, more specifically Macrosiphum avenae.

7. The use according to claim 5, characterized in that The nucleotide sequence of the dsRNA is shown in SEQ ID NO:

4.

8. A method for controlling aphids, characterized in that: Including targeting genes related to wheat aphid growth and development PLRP1 The step of administering the dsRNA to the aphids, for example, by spraying a pharmaceutical agent containing the dsRNA.

9. The method according to claim 8, characterized in that The aphid is wheat aphid, more specifically Macrosiphum avenae.

10. The method according to claim 8, characterized in that The nucleotide sequence of the dsRNA is shown in SEQ ID NO:4.